{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:38:02Z","timestamp":1776357482171,"version":"3.51.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,16]]},"DOI":"10.7759\/cureus.107169","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:35:38Z","timestamp":1776353738000},"source":"Crossref","is-referenced-by-count":0,"title":["Recognizing the Physiologic Signature of Oncologic Emergency: A Case of Burkitt Lymphoma Presenting With Early Laboratory Indicators of High Tumor Burden"],"prefix":"10.7759","author":[{"given":"Alireza","family":"Izadian Bidgoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gomez Veliz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00351-X","article-title":"Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet","volume":"12","author":"Ribrag V","year":"2025","unstructured":"Ribrag V, Bron D, Rymkiewicz G, et al.. Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet. Lancet Haematol. 2025, 12:E138-50. 10.1016\/S2352-3026(24)00351-X","journal-title":"Lancet Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105873","article-title":"Laboratory prognostic index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI","volume":"10","author":"Martin-Moro F","year":"2025","unstructured":"Martin-Moro F, Bento L, Marquet J, et al.. Laboratory prognostic index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI. ESMO Open. 2025, 10:105873. 10.1016\/j.esmoop.2025.105873","journal-title":"ESMO Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt's lymphoma","volume":"387","author":"Roschewski M","year":"2022","unstructured":"Roschewski M, Staudt LM, Wilson WH. Burkitt's lymphoma. N Engl J Med. 2022, 387:1111-22. 10.1056\/NEJMra2025746","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34618","article-title":"Incidence of Burkitt lymphoma in the United States during 2000 to 2019","volume":"153","author":"Mburu W","year":"2023","unstructured":"Mburu W, Devesa SS, Check D, Shiels MS, Mbulaiteye SM. Incidence of Burkitt lymphoma in the United States during 2000 to 2019. Int J Cancer. 2023, 153:1182-91. 10.1002\/ijc.34618","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004099","article-title":"The treatment of Burkitt lymphoma in adults","volume":"137","author":"Crombie J","year":"2021","unstructured":"Crombie J, LaCasce A. The treatment of Burkitt lymphoma in adults. Blood. 2021, 137:743-50. 10.1182\/blood.2019004099","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30126-5","article-title":"HIV-associated Burkitt lymphoma","volume":"7","author":"Atallah-Yunes S","year":"2020","unstructured":"Atallah-Yunes S, Murphy D, Noy A. HIV-associated Burkitt lymphoma. Lancet Haematol. 2020, 7:E594-605. 10.1016\/S2352-3026(20)30126-5","journal-title":"Lancet Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18115886","article-title":"Malaria infection and risk of endemic Burkitt lymphoma: a systematic review and meta-analysis","volume":"18","author":"Kotepui KU","year":"2021","unstructured":"Kotepui KU, Kotepui M. Malaria infection and risk of endemic Burkitt lymphoma: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021, 18:5886. 10.3390\/ijerph18115886","journal-title":"Int J Environ Res Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps G","year":"2022","unstructured":"Claps G, Faouzi S, Quidville V, Chehade F, Shen S, Vagner S, Robert C. The multiple roles of LDH in cancer. Nat Rev Clin Oncol. 2022, 19:749-62. 10.1038\/s41571-022-00686-2","journal-title":"Nat Rev Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012132","article-title":"Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice","volume":"20","author":"Bristol JA","year":"2024","unstructured":"Bristol JA, Nelson SE, Ohashi M, et al.. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice. PLoS Pathog. 2024, 20:e1012132. 10.1371\/journal.ppat.1012132","journal-title":"PLoS Pathog"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux EM","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, et al.. Burkitt's lymphoma. Lancet. 2012, 379:1234-44.","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt E","year":"2024","unstructured":"Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024, 403:1791-807. 10.1016\/S0140-6736(23)02705-8","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483930-recognizing-the-physiologic-signature-of-oncologic-emergency-a-case-of-burkitt-lymphoma-presenting-with-early-laboratory-indicators-of-high-tumor-burden","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:35:39Z","timestamp":1776353739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483930-recognizing-the-physiologic-signature-of-oncologic-emergency-a-case-of-burkitt-lymphoma-presenting-with-early-laboratory-indicators-of-high-tumor-burden"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.107169","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}